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ABSTRACT  
 
This study aimed to examine the mucolytic activity of roselle calyces extract on cow intestinal mucus in vitro. The extraction of roselle 
calyces was performed by the subsequence maceration method using different polarity solvent (n-hexane, ethyl acetate, and methanol). Mucolytic 
activity of each extract was evaluated by measuring the viscosity of mixture of cow intestinal mucus and phosphate buffer pH 7 compared to 
acetylcysteine as the standard mucolytic drug. The result showed that the decreasing of cow intestinal mucus and phosphate buffer pH 7 mixtures 
viscosity was indicated the increasing of mucolytic activity. The n-hexane, ethyl acetate, and methanol extract of roselle calyces exhibit dose-
dependent mucolytic activity. Mucolytic activity of roselle calyces ethyl acetate extract with dose of 0.8% and roselle calyces methanol extract 
with dose of 0.6% showed no significant difference to mucolytic activity from acetylcysteine with dose of 0.1% (positive control). An increased 
dose of roselle calyces extract will decrease the viscosity of cow intestinal mucus and phosphate buffer pH 7 mixtures, indicating an increase in 
mucolytic activity.  
____________________________________________________________________________________________________________________ 
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ABSTRAK 
 
Penelitian ini bertujuan mengetahui aktivitas mukolitik ekstrak bunga rosela secara in vitro terhadap mukus usus sapi. Ekstraksi bunga 
rosela dilakukan dengan metode maserasi bertingkat dengan menggunakan pelarut yang berbeda polaritas (n-heksana, etil asetat, dan metanol). 
Aktivitas mukolitik masing-masing ekstrak dievaluasi dengan cara diukur viskositas campuran mukus usus sapi dan dapar fosfat pH 7 
dibandingkan dengan asetilsistein sebagai obat mukolitik standar. Hasil penelitian menunjukkan bahwa penurunan viskositas campuran mukus 
usus sapi dan dapar fosfat pH 7 menunjukkan peningkatan aktivitas mukolitik. Ekstrak n-heksana, etil asetat, dan metanol dari bunga rosela 
menunjukkan aktivitas mukolitik yang bergantung terhadap dosis. Aktivitas mukolitik ekstrak etil asetat bunga rosela dengan dosis 0,8%; dan 
ekstrak metanol bunga rosela dengan dosis 0,6% tidak menunjukkan adanya perbedaan yang signifikan terhadap aktivitas mukolitik dari 
asetilsistein dengan dosis 0,1%.. Peningkatan dosis ekstrak bunga rosela akan menurunkan viskositas campuran mukus usus sapi dan dapar 
fosfat pH 7 yang mengindikasikan adanya peningkatan aktivitas mukolitik.  
____________________________________________________________________________________________________________________ 
Kata kunci: usus sapi, mukolitik, bunga rosela, mukus, viskositas 
 
 
INTRODUCTION 
 
A cough can occur in a healthy or sick condition 
and is a normal physiological response to foreign 
stimulants or irritation, serving a fundamental role in 
the respiratory tract protection and the maintenance of 
airway patency. It can occur voluntarily or in response 
to an airway irritation and can be both reflexive and 
non-reflexive (behavioral) in nature. Although 
coughing itself reflects a coordinated effort of the 
respiratory muscles, the underlying control mechanisms 
are dependent on complex neurophysiological events. 
The neural pathways that control a cough have been the 
subject of intense investigation in recent years, and 
much is now known about how voluntary and evoked a 
cough are generated (Keller et al., 2017). A cough can 
be divided into two types, namely a productive cough 
that produces sputum or mucus and a non-productive 
cough without the presence of sputum or mucus (De 
Blasio et al., 2011). 
Mucus secretion in the respiratory tract will cause 
blockage of the respiratory tract during respiratory 
process. To prevent the blockage of the respiratory tract, 
there is a natural mucus cleansing process. The 
production of over mucus will cause stimulation for the 
occurrence of a cough to remove excess mucus from the 
respiratory tract (Weinberger and Lockshin, 2017). 
Excessive mucus is excreted with the help of mucoactive 
agents. Administration of mucoactive agents aimed to 
increase the ability to expectorate sputum and/or 
decrease excessive mucus excretion. Mucoactive agents 
are divided into four groups: mucolytics, mucokinetics, 
mucoregulators, and expectorants. Mucolytics (acetyl-
cysteine and bromhexine) will change the physical and 
chemical properties by break down the glycoprotein 
bonds found in mucus into smaller molecules to reduce 
the viscosity of mucus so it will be easily coughed out 
and relieve shortness of breath (Hanson, 2017). 
Mucus is a complex liquid in the form of 
mucoproteins and mucopolysaccharides. Respiratory 
tract mucus has a composition of 97%-98% waters and 
2%-3% solids (mucin proteins, non-mucin proteins, 
salts, lipids, cellular debris) (Jacquot et al., 1992; Fahy 
and Dickey, 2010). Gastrointestinal mucus has a 
composition of 98% water and 2% solids (Pelaseyed et 
al., 2014). Due to the similarity of gastrointestinal 
mucus composition to respiratory tract mucus 
composition, then gastrointestinal mucus may serve as 
an in vitro model to replace respiratory tract mucus for 
mucolytic activity test. 
Herbal products have shown several activities for 
the treatment of respiratory disorders, such as 
mucolytic, expectorant, antitussive, nasal-decongestant, 
and antibacterial. The many advantages of herbal 
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medicine cause increased use of herbal medicines. 
Several studies have shown an association between 
phytochemical compounds contained in plants to the 
mucolytic effects of plants. The phytochemical 
compound contained in plants such as alkaloids, 
flavonoids, tannins, saponins, glycosides, steroids, and 
terpenoids are reported to have several synergistic 
effects for the treatment of a cough, such as mucolytics, 
mucokinetics, mucoregulators, expectorants, and 
antibacterial (Adesina et al., 2017). 
Roselle calyces has many pharmacological effects 
that have been studied in silico, in vitro, in situ and/or 
in vivo, including: immunomodulation (Kadri et al., 
2013), hepatoprotective (Ezzat et al., 2016), 
cardioprotective (Obouayeba et al., 2015), 
antidiabetic (Rosemary et al., 2014), antibacterial 
(Lusida et al., 2017), anticancer (Prabhakaran et al., 
2017), antihypertensive (Abubakar et al., 2015), 
antimalarial (Nerdy, 2017), antinociceptive (Ali et al., 
2011), anti-inflammatory (Ali et al., 2011; Obouayeba 
et al., 2015), and antidiarrheal (Ali et al., 2011). 
However, the mucolytic activity of roselle calyces has 
not been reported yet. Thus, in this study, the 
researchers were interested to examine the mucolytic 
effect of the roselle calyces extract by in vitro on cow 
intestinal mucus. 
 
MATERIALS AND METHODS 
 
Preparation of Extract 
This research used roselle calyces samples obtained 
from Wonosari, Tanjung Morawa, Deli Serdang, North 
Sumatera, Indonesia. The criteria of roselle calyces 
samples was fresh and dark red color. Samples were 
sorted, washed, drained, cut, dried, powdered, and 
sieved. Extract was prepared using stratified 
maceration with different polarity solvent, start with 
non-polar solvent (n-hexane), followed by semi-polar 
solvent (ethyl acetate), and ended with the polar solvent 
(methanol). Each solvent was macerated 2 times, the 
first maceration was carried out using 10 L solvent, 
stirred daily for 5 days (5x24 hours), and the second 
maceration was done using 5 L solvent, stirred daily for 
3 days (3x24 hours). Each aqueous extract was 
evaporated with a rotary evaporator until a viscous 
extract was obtained. The extracts obtained were tested 
for phytochemical content of alkaloids, flavonoids, 
tannins, saponins, glycosides, steroids, and terpenoids. 
 
Preparation of Cow Intestinal Mucus and 
Phosphate Buffer pH 7 Mixtures  
The cow intestinal is washed with running water, 
cut longitudinally, scraped mucous layer (not to the 
capillary blood vessels and fat), collected in beaker 
glass, stirred until homogeneous until the color turn to 
white yellowish and/or white brownish. Phosphate 
buffer pH 7 was prepared by mixed 125 mL of 0.2 M 
potassium dihydrogen phosphate with 72.75 mL of 0.2 
N sodium hydroxide solution and diluted up to 500 mL 
with CO2 free water. Mixture of cow intestinal mucus 
and phosphate buffer pH 7 was prepared by mixed 300 
g of cow intestinal mucus with 700 g of phosphate 
buffer pH 7 and stirred until homogeneous. 
 
Evaluation of Mucolytic Activity 
Negative control was prepared by mix 0.45 g tween 
80 with 29.55 g cow intestinal mucus and phosphate 
buffer pH 7 mixtures in a beaker glass, and stirred until 
homogenous. Positive control was prepared by adding 
0.03 g acetylcysteine  and 0.42 g tween 80 into beaker 
glass. The mixture was stirred until homogenous, added 
with 29.55 g cow intestinal mucus and phosphate buffer 
pH 7 mixtures, and then stirred until homogenous. The 
final concentration of acetylcysteine in the mixture was 
0.1%. Test sample prepared by adding 0.06 g, 0.12 g, 
0.18 g, 0.24 g, and 0.30 g of each extract into 0.39 g, 
0.33 g, 0.27 g, 0.18 g, and 0.15 g tween 80, respectively. 
The mixture was stirred until homogeneous, added with 
29.55 g cow intestinal mucus and phosphate buffer pH 7 
mixtures, and re-stirred until homogeneous. The final 
concentration of extract in the mixture was 0.2%, 0.4%, 
0.6%, 0.8%, and 1.0%. Composition of the mixture for 
negative control, positive control, and test sample are 
shown in Table 1. 
The sample of each treatment (negative control, 
positive control, and test sample) was incubated for 30 
min at 37° C. Each treatment performed in six 
repetitions. The viscosity of each treatment was 
measured by using viscometer and density 
measurements were made using pycnometer. Viscosity 
was calculated by multiplying the flow time and the 
density. The viscosity data were analyzed statistically 
with one-way analysis of variance (ANOVA) with 95% 
confidence level and least significant difference (LSD) 
technique. 
 
RESULTS AND DISCUSSION 
 
The extraction of roselle calyces using stratified 
maceration with different polarity of solvent (n-hexane, 
ethyl acetate, and methanol) to separate the chemical 
constituents contained in roselle calyces based on the 
solubility. Extraction of 1000 g of roselle calyces dried 
powder produced 31.8 g n-hexane extract (dark green), 
15.4 g of ethyl acetate extract (green), and 38.9 g of 
methanol extract (dark red). Phytochemical constituents 
Table 1. Composition of the mixture for negative control, positive control, and test sample 
No Item Control  Test sample ( – ) ( + )  0.2% 0.4% 0.6% 0.8% 1.0% 
1. Tween 80 0.45 0.42  0.39 0.33 0.27 0.21 0.15 
2. Acetylcysteine – 0.03  – – – – – 
3. Extract – –  0.06 0.12 0.18 0.24 0.30 
4. Mucus 29.55 29.55  29.55 29.55 29.55 29.55 29.55 
∑ Total 30.00 30.00  30.00 30.00 30.00 30.00 30.00 
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contained in roselle calyces extract (n-hexane, ethyl 
acetate, and methanol) are shown in Table 2. 
The phytochemical constituents contained in roselle 
calyces n-hexane extract are different and less than the 
ethyl acetate extract and the methanol extract of roselle 
calyces. The content in roselle calyces n-hexane extract 
differs from roselle calyces ethyl acetate extract and 
roselle calyces methanol extract, this is because the 
extraction by stratified maceration using different 
polarity of solvent principles is dissolves like. 
Compounds having similar polarity properties will be 
extracted in the same solvent polarity. Thus, in stratified 
maceration, different polarity of solvent will be extracted 
the different polarity compound (Altemimi, 2017). 
Further evaluation was carried out on mucolytic 
activity to cow intestinal mucus and phosphate buffer 
pH 7 mixtures with viscosity measurement of various 
treatments (negative control, positive control, and test 
sample) in vitro. Data of viscosity measurements of 
various treatments (negative control, positive control, 
and test sample) were shown in Table 3. 
The result data showed that roselle calyces extract 
had mucolytic activity shown by different viscosity 
between roselle calyces extract and negative control. 
The increasing of roselle calyces extract dose will 
cause decreasing of viscosity and indicating an increase 
of mucolytic activity, therefore, the mucolytic activity 
of roselle calyces extract was dose dependent. This is in 
accordance with previous studies of roselle calyces, 
which provide a various increasing activity with the 
increase of concentrations or doses, such as 
immunomodulation (Kadri et al., 2013), hepato-
protective (Ezzat et al., 2016), cardioprotective 
(Obouayeba et al., 2015), antidiabetic (Rosemary et al., 
2014), antibacterial (Lusida et al., 2017), anticancer 
(Prabhakaran et al., 2017), antihypertensive (Abubakar 
et al., 2015), antinociceptive (Ali et al., 2011), anti-
inflammatory (Ali et al., 2011; Obouayeba et al., 
2015), and antidiarrheal (Ali et al., 2011). 
Roselle calyces n-hexane extract in various doses 
of administration did not show a similar or stronger 
mucolytic activity to the positive control, proven by 
the higher viscosity in the administration of roselle 
calyces n-hexane extract than the viscosity in the 
administration 0.1% acetylcysteine. Roselle calyces 
ethyl acetate extract with dose 0.8% and roselle 
calyces methanol extract with dose 0.6% show a 
similar mucolytic activity to the positive control, 
demonstrated by the similar viscosity in the 
administration of roselle calyces ethyl acetate extract 
and roselle calyces methanol extract to the viscosity in 
the administration 0.1% acetylcysteine. Roselle 
calyces ethyl acetate extract with dose 1.0% and 
roselle calyces methanol extract with dose 0.8% and 
1.0% show a stronger mucolytic activity to the 
positive control, demonstrated by the lower viscosity 
in the administration of roselle calyces ethyl acetate 
extract and roselle calyces methanol extract than the 
viscosity in the administration 0.1% acetylcysteine. 
The administration of roselle calyces extract in 
various polarities and concentrations has mucolytic 
activity exhibited by significantly different viscosities 
Table 2. Phytochemical constituents contained in roselle calyces extract (n-hexane, ethyl acetate, and methanol) 
Number Compound Extract N-Hexane Ethyl acetate Methanol 
1 Alkaloids – + + 
2 Flavonoids – + + 
3 Saponins – + + 
4 Glycosides – + + 
5 Tannins + + + 
6 Steroids + – – 
7 Terpenoids + – – 
 
Table 3. Data of viscosity measurements of various treatments (negative control, positive control, and test sample) and subset 
results of one-way analysis of variance (ANOVA) with 95% confidence level and least significant difference (LSD) 
Number Treatment Viscosity (cP) Average±standard deviation 
Subset 
(Group) 
1 Negative control 7.2073±0.0055 A 
2 Positive control 7.1264±0.0035 I 
3 N-Hexane 0.2% 7.1938±0.0040 B 
4 N-Hexane 0.4% 7.1861±0.0036 C 
5 N-Hexane 0.6% 7.1759±0.0025 E 
6 N-Hexane 0.8% 7.1663±0.0024 F 
7 N-Hexane 1.0% 7.1575±0.0018 G 
8 Ethyl acetate 0.2% 7.1860±0.0023 C 
9 Ethyl acetate 0.4% 7.1656±0.0034 F 
10 Ethyl acetate 0.6% 7.1455±0.0029 H 
11 Ethyl acetate 0.8% 7.1239±0.0020 I 
12 Ethyl acetate 1.0% 7.1088±0.0039 J 
13 Methanol 0.2% 7.1811±0.0037 D 
14 Methanol 0.4% 7.1555±0.0032 G 
15 Methanol 0.6% 7.1280±0.0035 I 
16 Methanol 0.8% 7.1012±0.0029 K 
17 Methanol 1.0% 7.0753±0.0031 L 
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between roselle calyces extract and negative control. 
Not all polarity extracts and extract concentrations 
have a similar mucolytic activity to the positive 
control activity, but there are certain extract polarities 
and certain extracts concentrations that have a similar 
mucolytic activity to the positive control activity, and 
even certain extract polarities and certain extract 
concentrations are better than positive controls. The 
data show that the administration of roselle calyces 
ethyl acetate extract with dose of 0.8% and roselle 
calyces methanol extract with dose of 0.6% showed 
activity did not differ significantly with positive 
control. This may be due to phytochemical 
constituents contained in the extract (Muctahara et al., 
2017). Flavonoids contained in roselle calyces ethyl 
acetate extract and roselle calyces methanol extract 
(but not contained in roselle calyces n-hexane extract) 
are predicted to be responsible for better mucolytic 
effects than other compounds (Zhang and Zhou, 
2014). 
 
CONCLUSION 
 
An increased dose of roselle calyces extract will 
decrease the viscosity of cow intestinal mucus and 
phosphate buffer pH 7 mixtures, indicating an increase 
in mucolytic activity.  
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